Axon Enterprise, Inc $AXON Shares Sold by Resona Asset Management Co. Ltd.

Resona Asset Management Co. Ltd. lessened its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 35.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 93,227 shares of the biotechnology company’s stock after selling 50,122 shares during the period. Resona Asset Management Co. Ltd. owned approximately 0.11% of Axon Enterprise worth $39,368,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the stock. State Street Corp lifted its holdings in shares of Axon Enterprise by 5,700.2% in the second quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock valued at $119,724,905,000 after purchasing an additional 209,879,882 shares in the last quarter. Envestnet Asset Management Inc. boosted its stake in shares of Axon Enterprise by 18,050.2% during the second quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company’s stock valued at $7,400,094,000 after acquiring an additional 13,127,348 shares during the last quarter. BlackRock Inc. increased its position in Axon Enterprise by 4.3% during the 2nd quarter. BlackRock Inc. now owns 8,334,551 shares of the biotechnology company’s stock worth $4,672,432,000 after purchasing an additional 345,365 shares in the last quarter. Robeco Institutional Asset Management B.V. increased its position in Axon Enterprise by 391,214.9% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company’s stock worth $2,952,943,000 after purchasing an additional 6,987,098 shares in the last quarter. Finally, Assenagon Asset Management S.A. increased its position in Axon Enterprise by 5,022.8% during the 3rd quarter. Assenagon Asset Management S.A. now owns 4,266,589 shares of the biotechnology company’s stock worth $1,802,719,000 after purchasing an additional 4,183,302 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Trading Down 5.2%

NASDAQ AXON opened at $291.13 on Friday. Axon Enterprise, Inc has a 12 month low of $289.68 and a 12 month high of $665.07. The company has a 50-day moving average of $398.48 and a 200-day moving average of $462.93. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.00 and a quick ratio of 2.60. The company has a market cap of $23.71 billion, a P/E ratio of 93.31, a P/E/G ratio of 5.82 and a beta of 1.48.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings data on Friday, November 6th. The biotechnology company reported $1.72 earnings per share for the quarter, missing the consensus estimate of $1.89 by ($0.17). Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The company had revenue of $908.55 million for the quarter, compared to analysts’ expectations of $934.33 million. During the same quarter in the previous year, the company earned $1.17 earnings per share. The company’s revenue was up 27.8% on a year-over-year basis. As a group, equities analysts predict that Axon Enterprise, Inc will post 1.65 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages recently weighed in on AXON. Morgan Stanley boosted their target price on shares of Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. UBS Group raised their price target on shares of Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a research note on Thursday, August 6th. Piper Sandler reiterated an “overweight” rating and set a $540.00 price target (down from $561.00) on shares of Axon Enterprise in a report on Friday, November 6th. The Goldman Sachs Group lowered their price target on shares of Axon Enterprise from $715.00 to $675.00 and set a “buy” rating for the company in a report on Monday, September 21st. Finally, Argus boosted their price target on Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, September 3rd. Thirteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average price target of $612.18.

Get Our Latest Report on AXON

Insider Buying and Selling

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total value of $5,089,900.00. Following the transaction, the chief executive officer owned 3,118,012 shares in the company, valued at $1,587,036,927.88. This trade represents a 0.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the business’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the sale, the president directly owned 296,974 shares of the company’s stock, valued at $170,590,774.82. This represents a 5.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 27,792 shares of company stock valued at $15,214,581. Insiders own 4.20% of the company’s stock.

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.

Further Reading

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.